Analytic model comparing the cost utility of TVT versus duloxetine in women with urinary stress incontinence

International Urogynecology Journal

Volumn 21, Issue 8, 2010, Pages 977-984

  Jacklin, Paul ^a   Duckett, Jonathan ^b   Renganathan, Arasee ^b  

^a National Collaborating Centre for Women's and Children's Health   (United Kingdom)

^b MEDWAY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cost effectiveness; Duloxetine; QALY; Stress incontinence; TVT

Indexed keywords

DULOXETINE;

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FOLLOW UP; HEALTH CARE COST; INTERMETHOD COMPARISON; OUTCOME ASSESSMENT; PELVIC FLOOR MUSCLE TRAINING; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; STATISTICAL MODEL; STRESS INCONTINENCE; TENSION FREE VAGINAL TAPE;

EID: 77956456743     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-010-1132-2     Document Type: Article

References (23)

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2002) The standardisation of the terminology of lower urinary tract function. Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167
2. Hannestad YS, Rortveit G, Sandvik H, Hunskaar S (2000) A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of incontinence in the County of Nord-Trondelag. J Clin Epidemiol 53:1150-1157
3. Iyengar S, Webster AA, Hemrick-Luecke SK, Xu JY, Simmons RM (2004) Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J Pharmacol Exp Ther 311 (2):576-584
4. Jost WH, Marsalek P (2005) Duloxetine in the treatment of stress urinary incontinence. Ther Clin Risk Manag 1 (4):259-264
5. Duckett JR, Vella M, Kavalakuntla G, Basu M (2007) Tolerability and efficacy of duloxetine in a nontrial situation. BJOG 114 (5):543-547
6. Mariappan P, Ballantyne Z, N'Dow JM, Alhasso AA (2005) Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Cochrane Database Syst Rev 20 (3): CD004742
7. Vella M, Duckett J, Basu M (2008) Duloxetine 1 year on: the long-term outcome of a cohort of women prescribed duloxetine. Int Urogynecol J Pelvic Floor Dysfunct 19 (7):961-964
8. Ankardal M, Järbrink K, Milsom I, Heiwall B, Lausten-Thomsen N, Ellstrüm-Engh M (2007) Comparison of health care costs for open Burch colposuspension, laparoscopic colposuspension and tension-free vaginal tape in the treatment of female urinary incontinence. Neurourol Urodyn 26 (6):761-766
9. Manca A, Sculpher MJ, Ward K, Hilton P (2003) A cost-utility analysis of tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence. BJOG 110 (3):255-262 (Pubitemid 36298907)
10. National Institute of Clinical Excellence (2006) Urinary incontinence. The management of urinary incontinence in women, Available online at: http://www.nice.org.uk/nicemedia/pdf/CG40fullguidelinepdf. Accessed 27 Dec. 2009
11. National Institute for Health and Clinical Excellence (2007) The guidelines manual. National Institute for Health and Clinical Excellence, London, Available from: www.nice.org.uk. Accessed 27 Dec. 2009
12. Brunenberg DE, Joore MA, Veraart CP, Berghmans BC, van der Vaart CH, Severens JL (2006) Economic evaluation of duloxetine for the treatment of women with stress urinary incontinence: a Markov model comparing pharmacotherapy with pelvic floor muscle training. Clin Ther 28:604-618
13. Wu JM, Visco AG, Weidner AC, Myers ER (2007) Is Burch colposuspension ever cost-effective compared with tension-free vaginal tape for stress incontinence? Am J Obstet Gynecol 197(62):e1-e5
14. Ward K, Hilton P, United Kingdom and Ireland Tension-free Vaginal Tape Trial Group (2002) Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence. BMJ 325 (7355):67-73
15. Cody J, Wyness L, Wallace S, Glazener C, Kilonzo M, Stearns S et al (2003) Systematic review of the clinical effectiveness and cost-effectiveness of tension-free vaginal tape for treatment of urinary stress incontinence. Health Technol Assess 7 (21):1-189
16. Gupta RD, Caiado M, Bamber L (2006) An evaluation of the costeffectiveness of duloxetine as a treatment for women with moderateto-severe stress urinary incontinence. J Med Econ 9:1-25
17. Mittmann N, Trakas K, Risebrough N, Liu BA (1999) Utility scores for chronic conditions in a community-dwelling population. Pharmacoeconomics 15 (4):369-376
18. O'Brien BJ, Goeree R, Bernard L, Rosner A, Williamson T (2001) Cost-effectiveness of tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: a Canadian perspective. Clin Ther 23 (12):2038-2049
19. Schultz SE, Kopec JA (2003) Impact of chronic conditions. Health Rep 14 (4):41-53
20. Ward KL, Hilton P, UK and Ireland TVT Trial Group (2004) A prospective multicenter randomized trial of tension-free vaginal tape and colposuspension for primary urodynamic stress incontinence: two-year follow-up. Am J Obstet Gynecol 190 (2):324-331
21. Nilsson CG, Palva K, Rezapour M, Falconer C (2008) Eleven years prospective follow-up of the tension free vaginal tape procedure for treatment of stress urinary incontinence. Int Urogynecol J 19:1043-1047
22. Ward KL, Hilton P, UK and Ireland TVT Trial Group (2008) Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow up. BJOG 115 (2):226-233
23. Bump RC, Voss S, Beardsworth A, Manning M, Zhao YD, Chen W (2008) Long-term efficacy of duloxetine in women with stress urinary incontinence. BJU Int 102:214-218